Success Rate of 4 Injection Protocols for Mandibular First Molars With Symptomatic Irreversible Pulpitis
Root Canal Infection
About this trial
This is an interventional treatment trial for Root Canal Infection focused on measuring intra-osseous injection, PDL injection, IANB
Eligibility Criteria
Inclusion Criteria:
- Patients included in the study were healthy males and females
- (Category: American Society of Anesthesiologists class 1)
- aged 21-49 years
- with no physical disability, facial paresthesia or psychological problems
- presenting with a single vital mature mandibular first molar, with signs and/or symptoms of symptomatic irreversible pulpitis
Exclusion Criteria:
- Pregnant women
- patients who took analgesics or other medications that would alter the inflammatory response of the pulp or provide analgesia 6- hours pre-operatively
- those with known sensitivity to the pharmaceuticals used in this trial.
- those with pathological periodontal pockets
Sites / Locations
- Ain Shams University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Active Comparator
Active Comparator
Active Comparator
IANB/inferior alveolar nerve block
IANB+IO
IANB+PDL
IANB+BI
patients will be given standard IANB with 3.6 ml Articaine HCL 4% with 1:100,000 adrenaline (Artinibsa, Inibsa, Barcelona, Spain).
patients will be given standard IANB plus an intra-osseous with 3.6 ml Articaine HCL 4% with 1:100,000 adrenaline (Artinibsa, Inibsa, Barcelona, Spain).
patients will be given standard IANB plus a PDL injection with 3.6 ml Articaine HCL 4% with 1:100,000 adrenaline (Artinibsa, Inibsa, Barcelona, Spain).
patients will be given standard IANB plus a BI injection with 3.6 ml Articaine HCL 4% with 1:100,000 adrenaline (Artinibsa, Inibsa, Barcelona, Spain).